Delivery Order SPE2DB25D3201-SPE2DB25FNURU
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,205.76 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for a delivery order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA). The $3,201.81 firm fixed price contract has a completion date of July 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of Amerisourcebergen's substantial Indefinite Delivery...
- The federal contract award summarized is for the delivery of LINZESS 145 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $15,038.86 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 2, 2025, with a completion date of February 3, 2025. This appears to be a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support...
- The federal contract award is for the delivery of Linzess 72 MCG Capsule medical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,152.44 and is a delivery order with a firm fixed-price pricing type. The ultimate completion date is December 5, 2023. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award, valued at $1,654.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award is for the delivery of LINZESS 72 MCG CAPSULE medication to the Defense Logistics Agency (DLA). The $1,221.18 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024, with a completion date of November 1, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.94 Firm Fixed Price Delivery Order is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and was awarded on July 1, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.40 firm fixed-price delivery order is for LINZESS 145 MCG CAPSULE UU 30S, with a performance period ending on May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, with a ceiling value of $3,793.67 and a completion date of June 18, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,260.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of LINZESS 145 MCG CAPSULE, a medication, with a performance period ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...